Jan Geliebter
- Immunology top 5%
- Immunotherapy and Immune Responses 12
- Immune Cell Function and Interaction 9
- T-cell and B-cell Immunology 6
-
- Thyroid Cancer Diagnosis and Treatment 22
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 9
- Molecular Biology top 10%
- Oncology top 10%
- Cancer-related Molecular Pathways 6
-
- Estrogen and related hormone effects 9
-
- Dermatology and Skin Diseases 7
- Co-authors
- S.G. NathensonRaj K. TiwariR A ZeffGertrude M. PfaffenbachRoger W. MelvoldRobert SurianoNiradiz ReyesShilpi Rajoria
- Journals
- Proceedings of the National Academy of Sciences (1 paper)The Journal of Experimental Medicine (2 papers)PLoS ONE (1 paper)
- Partner nations
- United StatesColombiaChina
In The Last Decade
Jan Geliebter
100 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 126
- Immunology 515
- Endocrinology, Diabetes and Metabolism 371
- Cancer Research 230
- Molecular Biology 944
- Oncology 299
Countries citing papers authored by Jan Geliebter
This map shows the geographic impact of Jan Geliebter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Geliebter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Geliebter more than expected).
Fields of papers citing papers by Jan Geliebter
This network shows the impact of papers produced by Jan Geliebter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Geliebter. The network helps show where Jan Geliebter may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jan Geliebter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 7 | |
| 7 | 2023 | 5 | |
| 8 | 2021 | 19 | |
| 9 | 2019 | 10 | |
| 10 | 2018 | 16 | |
| 11 | 2011 | 52 | |
| 12 | 2011 | 37 | |
| 13 | 2011 | 33 | |
| 14 | 5-lipoxygenase and 15-lipoxygenase-2 expression in papillary thyroid carcinoma: Potential therapeutic targets and prognostic markers | 2006 | 1 |
| 15 | 2004 | 3 | |
| 16 | 2004 | 26 | |
| 17 | 1993 | 5 | |
| 18 | 1993 | 2 | |
| 19 | 1988 | 9 | |
| 20 | 1988 | 36 |
About Jan Geliebter
Jan Geliebter is a scholar working on Cancer Research, Endocrinology, Diabetes and Metabolism and Immunology and Allergy, having authored 109 papers that have together received 2.2k indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (22 papers), Immunotherapy and Immune Responses (12 papers), Immune Cell Function and Interaction (9 papers), Estrogen and related hormone effects (9 papers), Cancer-related molecular mechanisms research (9 papers), Dermatology and Skin Diseases (7 papers), Cancer-related Molecular Pathways (6 papers) and T-cell and B-cell Immunology (6 papers). The work is most often cited by research in Immunology (515 citations), Endocrinology, Diabetes and Metabolism (371 citations) and Cancer Research (230 citations). Jan Geliebter has collaborated with scholars based in United States, Colombia and China. Frequent co-authors include S.G. Nathenson, Raj K. Tiwari, R A Zeff, Gertrude M. Pfaffenbach, Roger W. Melvold, Robert Suriano, Niradiz Reyes, Shilpi Rajoria, Stimson P. Schantz and Augustine Moscatello. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.